ESI-GROUP
8.6.2021 14:02:09 CEST | Business Wire | Press release
Regulatory News:
ESI Group (Paris:ESI), a global player in virtual prototyping for industries, participates in the successful development phase of the Nivus made by Volkswagen do Brazil: 100% digitally and virtually – a world premiere. The process began before the pandemic and was completed during the COVID-19 period, applying all the sanitary measures in place. Thanks to Virtual Prototyping/Digital Development (a change in product development), time was shortened in about 10 months and saved a few million euros in prototype production costs: Would it be a shift in the industry?
Making the right decision, quickly and 100% digitally
Usually, when a new vehicle is developed, time and physical prototypes are required both during the design and assembly preparation phases. In the case of the Nivus, launched in a live broadcast by Volkswagen do Brazil in June 2020 to around 60 countries, the whole conception of the vehicle was made 100% virtually.
The state-of-the-art solution provided by ESI Group, based on its software IC.IDO
was one of the tools used to design reviews and engineering decisions in different departments (product development, operations, quality, etc). This allowed Volkswagen to make informed decisions regarding the car’s conception. It provided the automotive company with the opportunity to save time (shortened the car’s development in about 10 months) and investment (for example, only in the Virtual Prototype Laboratory there was a 65% reduction of costs compared to previous projects).
Virtual reality also conserves tons of paper, in which specifications for each part of a car were previously detailed.
Long before Nivus physically existed, the vehicle was already available digitally in the engineering computers. Considering that building a physical prototype takes 19 weeks, in which only a single vehicle variant is possible. For this vehicle, nine virtual variants were produced, in much less time, which made it possible to anticipate more efficient assembly procedures, reducing the number of processes in the simulations and avoiding errors, since all parts were previously tested with digital tools.
"We designed 100% of the Nivus with digital processes using, among others, ESI’s technology without the need to assemble a single physical prototype. In addition, with the drastic reduction of the development time, this solution helps us to integrate all our different teams, from various department (design, engineering, marketing, production, etc) in the same decision-making process. It was a more efficient but also more collaborative process. " explains Francisvaldo Gomes Aires, Prototyping Development Manager at Volkswagen do Brazil.
Virtual reality: A huge benefit during COVID-19
ESI demonstrated that even when the design phase is impacted, in this case by COVID-19, it is possible to continue with the project, since it is no longer a question of relying solely on physical reality. This opens up the possibility of experiencing the future with digitalization and technology for the project benefit.
“It’s a shift in the industrial production. For the first time, all phases of a car release, before the effective production, has been fully made virtually making the production feasible during Covid-19 time. While allowing Volkswagen to take all its design and manufacturing decisions virtually, we helped them produce faster, cheaper and in a more sustainable way. This was possible due to a strong support of our local Brazilian team and a mutual collaboration between ESI Brazil and Volkswagen do Brazil. We all feel proud to be part of this world-premiere alongside with Volkswagen and its partners.” declares Andreas Renner, Volkswagen Global Account Manager – ESI Group.
About ESI Group
Founded in 1973, ESI Group is a leading innovator in Virtual Prototyping solutions and a global enabler of industrial transformation. Thanks to the company’s unique know-how in the physics of materials, it has developed and refined, over the last 45 years, advanced simulation capabilities. Having identified gaps in the traditional approach to Product Lifecycle Management (PLM), ESI has introduced a holistic methodology centered on industrial productivity and product performance throughout its entire lifecycle, i.e. Product Performance Lifecycle™, from engineering to manufacturing and in operation. Present in more than 20 countries, and in major industrial sectors, ESI employs 1200 high level specialists around the world and reported 2020 sales of €132.6 million. ESI is headquartered in France and is listed on compartment B of Euronext Paris.
For further information, go to www.esi-group.com .
Follow ESI
http://www.esi-group.com/linkedin
http://www.esi-group.com/facebook
http://www.esi-group.com/twitter
http://www.esi-group.com/youtube
View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005672/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release
SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release
Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a
Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release
Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release
GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc
Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release
Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
